Cargando…

Peroxisome Proliferator-Activated Receptor α Activation Induces Hepatic Steatosis, Suggesting an Adverse Effect

Non-alcoholic fatty liver disease (NAFLD) is characterized by hepatic triglyceride accumulation, ranging from steatosis to steatohepatitis and cirrhosis. NAFLD is a risk factor for cardiovascular diseases and is associated with metabolic syndrome. Antihyperlipidemic drugs are recommended as part of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Fang, Wang, Qi, Xu, Chao, Cao, Mingfeng, Zhou, Xiaoming, Wang, Tingting, Yu, Chunxiao, Jing, Fei, Chen, Wenbin, Gao, Ling, Zhao, Jiajun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057124/ https://www.ncbi.nlm.nih.gov/pubmed/24926685 http://dx.doi.org/10.1371/journal.pone.0099245

Ejemplares similares

Peroxisome proliferator-activated receptor δ agonist attenuates hepatic steatosis by anti-inflammatory mechanism
por: Lee, Mi Young, et al.
Publicado: (2012)

Role of peroxisome proliferator‐activated receptor gamma agonist in improving hepatic steatosis: Possible molecular mechanism
por: Park, Cheol‐Young, et al.
Publicado: (2012)

Activation of Peroxisome Proliferator-Activated Receptor Gamma by Rosiglitazone Increases Sirt6 Expression and Ameliorates Hepatic Steatosis in Rats
por: Yang, Soo Jin, et al.
Publicado: (2011)

Selective peroxisome proliferator-activated receptorα modulators (SPPARMα): The next generation of peroxisome proliferator-activated receptor α-agonists
por: Fruchart, Jean-Charles
Publicado: (2013)

Impact of peroxisome proliferator-activated receptor-α on diabetic cardiomyopathy
por: Wang, Lin, et al.
Publicado: (2021)

Concurrent Activation of Liver X Receptor and Peroxisome Proliferator-Activated Receptor Alpha Exacerbates Hepatic Steatosis in High Fat Diet-Induced Obese Mice
por: Gao, Mingming, et al.
Publicado: (2013)

Selective peroxisome proliferator‐activated receptor‐α modulator K‐877 efficiently activates the peroxisome proliferator‐activated receptor‐α pathway and improves lipid metabolism in mice
por: Takei, Kenta, et al.
Publicado: (2017)

Activation of peroxisome proliferator-activated receptor-α in mice induces expression of the hepatic low-density lipoprotein receptor
por: Huang, Z, et al.
Publicado: (2008)

Pharmacologic activation of peroxisome proliferator-activating receptor-α accelerates hepatic fatty acid oxidation in neonatal pigs
por: Shim, Kwanseob, et al.
Publicado: (2018)

Role of Peroxisome Proliferator-Activated Receptor α in Diabetic Nephropathy
por: Chung, Sungjin, et al.
Publicado: (2011)

Osteoarthritis: Role of Peroxisome Proliferator-Activated Receptors
por: Sheng, Weibei, et al.
Publicado: (2023)

Expression of the Peroxisome Proliferator-Activated Receptors (PPARs) in the Hepatic Stellate Cells
por: Sato, Takeya, et al.
Publicado: (2004)

Impaired T cell-mediated hepatitis in peroxisome proliferator activated receptor alpha (PPARα)-deficient mice
por: Hines, Ian N., et al.
Publicado: (2018)

Peroxisome Proliferator–Activated Receptor-α: A Pivotal Regulator of the Gastrointestinal Tract
por: Guo, Yue-Xin, et al.
Publicado: (2022)

Peroxisome Proliferator-Activated Receptor α Activation Protects Retinal Ganglion Cells in Ischemia-Reperfusion Retinas
por: Yao, Fei, et al.
Publicado: (2021)

Hepatic lipid homeostasis by peroxisome proliferator-activated receptor gamma 2()
por: Lee, Yoon Kwang, et al.
Publicado: (2018)

Regulation of Proteome Maintenance Gene Expression by Activators of Peroxisome Proliferator-Activated Receptor α
por: Ren, Hongzu, et al.
Publicado: (2010)

Impact of Oxidative Stress and Peroxisome Proliferator–Activated Receptor γ Coactivator-1α in Hepatic Insulin Resistance
por: Kumashiro, Naoki, et al.
Publicado: (2008)

Inhibition of Aldose Reductase Activates Hepatic Peroxisome Proliferator-Activated Receptor-α and Ameliorates Hepatosteatosis in Diabetic db/db Mice
por: Qiu, Longxin, et al.
Publicado: (2012)

Corrigendum: Peroxisome proliferator–activated receptor-α: A pivotal regulator of the gastrointestinal tract
por: Guo, Yue-Xin, et al.
Publicado: (2022)

Anti-hypertensive and cardioprotective effects of a novel apitherapy formulation via upregulation of peroxisome proliferator-activated receptor-α and -γ in spontaneous hypertensive rats
por: Sun, Yanru, et al.
Publicado: (2018)

The mechanistic target of rapamycin complex 1 pathway involved in hepatic gluconeogenesis through peroxisome-proliferator-activated receptor γ coactivator-1α
por: Wang, Guoyan, et al.
Publicado: (2022)

Upregulation of peroxisome proliferator-activated receptor-α and the lipid metabolism pathway promotes carcinogenesis of ampullary cancer
por: Wang, Chih-Yang, et al.
Publicado: (2021)

Aleglitazar, a dual peroxisome proliferator-activated receptor-α and -γ agonist, protects cardiomyocytes against the adverse effects of hyperglycaemia
por: Chen, Yan, et al.
Publicado: (2017)

Increased hepatic oxidative metabolism distinguishes the action of Peroxisome proliferator-activated receptor δ from Peroxisome proliferator-activated receptor γ in the ob/ob mouse
por: Roberts, Lee D, et al.
Publicado: (2009)

Targeting peroxisomal fatty acid oxidation improves hepatic steatosis and insulin resistance in obese mice
por: Yao, Haoya, et al.
Publicado: (2022)

Chondrosarcoma and Peroxisome Proliferator-Activated Receptor
por: Nishida, K., et al.
Publicado: (2008)

Peroxisome proliferator-activated receptor α as a novel therapeutic target for schizophrenia
por: Wada, Yuina, et al.
Publicado: (2020)

Salidroside Ameliorates Cardiomyocyte Hypertrophy by Upregulating Peroxisome Proliferator-Activated Receptor-α
por: Gao, Hui, et al.
Publicado: (2022)

Peroxisome Proliferator-Activated Receptor α in Lipoprotein Metabolism and Atherosclerotic Cardiovascular Disease
por: Fuior, Elena Valeria, et al.
Publicado: (2023)

Peroxisome Proliferator-Activated Receptor α (PPARα) down-regulation in cystic fibrosis lymphocytes
por: Reynders, Veerle, et al.
Publicado: (2006)

Examination of Ligand-Dependent Coactivator Recruitment by Peroxisome Proliferator-Activated Receptor-α (PPARα)
por: Tien, Eric S., et al.
Publicado: (2006)

Ligand-Regulated Heterodimerization of Peroxisome Proliferator-Activated Receptor α with Liver X Receptor α
por: Balanarasimha, Madhumitha, et al.
Publicado: (2014)

Partial Resistance to Peroxisome Proliferator–Activated Receptor-α Agonists in ZDF Rats Is Associated With Defective Hepatic Mitochondrial Metabolism
por: Satapati, Santhosh, et al.
Publicado: (2008)

Myricetin Increases Hepatic Peroxisome Proliferator-Activated Receptor α Protein Expression and Decreases Plasma Lipids and Adiposity in Rats
por: Chang, Chia Ju, et al.
Publicado: (2012)

Hepatoprotective role of peroxisome proliferator-activated receptor-α in non-cancerous hepatic tissues following transcatheter arterial embolization
por: Yang, Peiyu, et al.
Publicado: (2022)

Inhibition of DHCR24 activates LXRα to ameliorate hepatic steatosis and inflammation
por: Zhou, Enchen, et al.
Publicado: (2023)

Peroxisome Proliferator–activated Receptors α and γ Down-regulate Allergic Inflammation and Eosinophil Activation
por: Woerly, Gaetane, et al.
Publicado: (2003)

Peroxisome Proliferator-Activated Receptors and Hepatitis C Virus-Induced Insulin Resistance
por: Negro, Francesco
Publicado: (2009)

Hepatic Peroxisome Proliferator-Activated Receptor Alpha Dysfunction in Porcine Septic Shock
por: Vandewalle, Jolien, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_73m5ovh0mres2ms4rbqv2rttmg